Michael Lampert > Ropes & Gray LLP > Boston, United States > Lawyer Profile
Ropes & Gray LLP Offices

800 BOYLSTON STREET
BOSTON, MA 02199
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Michael Lampert

Work Department
Michael Lampert provides strategic, regulatory, and transactional advice to clients including health systems, colleges, universities, schools of medicine and academic medical centers, medical device and pharmaceutical companies, investors, physician practices, laboratories, and emerging providers. Recently, Michael has provided critical guidance to clients on a variety of legal and regulatory issues associated with the COVID-19 pandemic, including advising on practices and policies related to COVID-19 in view of public health guidance, and helping clients navigate evolving developments in state and federal guidelines.
Michael has extensive familiarity with fraud and abuse laws, in both an advisory and enforcement context, conflicts of interest standards, and other regulation such as Medicare reimbursement rules, requirements of the LCME and other accreditation bodies, the Food, Drug & Cosmetic Act, and HIPAA. Michael also advises in mergers, acquisitions, restructurings, affiliations, and financings in both the for-profit and nonprofit context. In addition, Michael guides clients in rigorous compliance program assessment and development projects against the backdrop of, and as a component of, investigations arising from allegations of significant noncompliance.
Top Tier Firm Rankings
- Investment fund formation and management > Alternative/hedge funds
- Finance > Financial services regulation
- Dispute resolution > E-discovery
- Dispute resolution > Securities litigation: defense
- Dispute resolution > M&A litigation: defense
- Healthcare > Life sciences
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Healthcare > Service providers
Firm Rankings
- Finance > Capital markets: high-yield debt offerings
- Finance > Capital markets: equity offerings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Tax > Not-for-profit (Fortune 1000 private foundations, national trade associations, and charities)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Tax > US taxes: non-contentious
- Antitrust > Cartel
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (International Trade Commission)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Government > State attorneys general
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Finance > Fintech
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Antitrust > Civil litigation/class actions: defense
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Structured finance: securitization
- International trade and national security > Customs, export controls and economic sanctions
- M&A/corporate and commercial > Shareholder activism